The Clinical Study is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE
Philadelphia, Pennsylvania -
Newsfile Corp. - February 27, 2025 - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has submitted a clinical design (SKNJCT-004) to UAE...
Read more: Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to UAE Department...